CYP2C9 genotyping in acenocoumarol treatment: is it a cost-effective addition to international normalized ratio monitoring?

Tom Schalekamp; Gerard J J Boink; Loes E Visser; Bruno H Ch Stricker; Anthonius de Boer; Olaf H Klungel

doi:10.1016/j.clpt.2006.03.008

CYP2C9 genotyping in acenocoumarol treatment: is it a cost-effective addition to international normalized ratio monitoring?

Tom Schalekamp, Gerard J J Boink, Loes E Visser, Bruno H Ch Stricker, Anthonius de Boer, Olaf H Klungel

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	511-520
Number of pages	10
Journal	Clinical Pharmacology and Therapeutics
Volume	79
Issue number	6
DOIs	https://doi.org/10.1016/j.clpt.2006.03.008
Publication status	Published - Jun 2006

Keywords

Acenocoumarol
Anticoagulants
Aryl Hydrocarbon Hydroxylases
Blood Coagulation Disorders
Cost-Benefit Analysis
Cytochrome P-450 CYP2C9
Genotype
Humans
International Normalized Ratio
Models, Statistical
Netherlands

Access to Document

10.1016/j.clpt.2006.03.008

Cite this

@article{b309453395a2438d90241faaf594a588,

title = "CYP2C9 genotyping in acenocoumarol treatment: is it a cost-effective addition to international normalized ratio monitoring?",

keywords = "Acenocoumarol, Anticoagulants, Aryl Hydrocarbon Hydroxylases, Blood Coagulation Disorders, Cost-Benefit Analysis, Cytochrome P-450 CYP2C9, Genotype, Humans, International Normalized Ratio, Models, Statistical, Netherlands",

author = "Tom Schalekamp and Boink, {Gerard J J} and Visser, {Loes E} and Stricker, {Bruno H Ch} and {de Boer}, Anthonius and Klungel, {Olaf H}",

year = "2006",

month = jun,

doi = "10.1016/j.clpt.2006.03.008",

language = "English",

volume = "79",

pages = "511--520",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Nature Publishing Group",

number = "6",

}

TY - JOUR

T1 - CYP2C9 genotyping in acenocoumarol treatment

T2 - is it a cost-effective addition to international normalized ratio monitoring?

AU - Schalekamp, Tom

AU - Boink, Gerard J J

AU - Visser, Loes E

AU - Stricker, Bruno H Ch

AU - de Boer, Anthonius

AU - Klungel, Olaf H

PY - 2006/6

Y1 - 2006/6

KW - Acenocoumarol

KW - Anticoagulants

KW - Aryl Hydrocarbon Hydroxylases

KW - Blood Coagulation Disorders

KW - Cost-Benefit Analysis

KW - Cytochrome P-450 CYP2C9

KW - Genotype

KW - Humans

KW - International Normalized Ratio

KW - Models, Statistical

KW - Netherlands

U2 - 10.1016/j.clpt.2006.03.008

DO - 10.1016/j.clpt.2006.03.008

M3 - Article

C2 - 16765138

SN - 0009-9236

VL - 79

SP - 511

EP - 520

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 6

ER -